CT Financial Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$10.4K Sell
525
-5
-0.9% -$112 0.01% 435
2016
Q4
$12.8K Sell
530
-176
-25% -$4.9K 0.01% 401
2016
Q3
$19.6K Sell
706
-1,312
-65% -$34.7K 0.01% 356
2016
Q2
$49.2K Sell
2,018
-605
-23% -$17.2K 0.03% 270
2016
Q1
$88.1K Hold
2,623
0.05% 219
2015
Q4
$78.4K Buy
2,623
+1,513
+136% +$51K 0.05% 243
2015
Q3
$35K Buy
1,110
+833
+301% +$40.6K 0.02% 328
2015
Q2
$13.4K Buy
277
+94
+51% +$3.96K 0.01% 430
2015
Q1
$7.94K Buy
+183
New +$6.58K ﹤0.01% 486
2014
Q1
$7.94K Buy
+183
New +$5.07K ﹤0.01% 486

Other funds holding PGEN

CT Financial Advisors's PGEN Position: Q1 2017 in Review

CT Financial Advisors reduced its Precigen (PGEN) stake by 0.94% in Q1 2017, selling an estimated $112 and leaving 525 shares worth $10.4K. The position accounts for 0.01% of the portfolio, ranked #435.

CT Financial Advisors first reported a position in PGEN in Q1 2014 and has held it in 10 quarters since. The position peaked at $88.1K in Q1 2016. 154 funds tracked by Wall St. Rank hold PGEN as of Q1 2017.

  • CT Financial Advisors held 525 shares of Precigen worth $10.4K as of Q1 2017.
  • CT Financial Advisors sold 5 Precigen shares in Q1 2017, an estimated $112.
  • Precigen made up 0.01% of CT Financial Advisors's portfolio in Q1 2017, its #435 holding.
  • CT Financial Advisors first reported a position in Precigen in Q1 2014 and has held it in 10 quarters since.
  • CT Financial Advisors's Precigen position peaked at $88.1K in Q1 2016.
  • 154 funds tracked by Wall St. Rank held Precigen as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.